Physician profile
Vinod Patel
NPI 1609814490
$37,375.07
in general payments reported to CMS, 2019-2025
64 companies · $9,365 in 2025
The $9,365 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,256 · 2020: $2,363 · 2021: $4,584 · 2022: $4,276 · 2023: $6,282 · 2024: $6,248 · 2025: $9,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Honoraria: $4,800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200 · Education: $100 · Travel and Lodging: $38.67 · Consulting Fee: $21.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,735.30 |
| Honoraria | $4,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
| Education | $100.21 |
| Travel and Lodging | $38.67 |
| Consulting Fee | $21.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $6,885.20 | 2024-2025 | |
| Abbott Laboratories | $4,672.82 | 2019-2025 | Aveir, Diamondback Peripheral, Jot Dx |
| Cvrx, INC. | $2,938.55 | 2021-2024 | Barostim Neo System |
| Novo Nordisk INC | $2,135.48 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boston Scientific Corporation | $2,027.87 | 2019-2025 | Opticross, Avvigo Guidance System, Resonate El Icd Vr |
| Janssen Pharmaceuticals, INC | $1,793.24 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $1,535.79 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Bardy Diagnostics, INC. | $1,283.37 | 2021-2022 | |
| Medtronic Vascular, INC. | $1,269.30 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,109.94 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $1,096.91 | 2021-2025 | |
| Lilly USA, LLC | $1,089.80 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Medtronic, INC. | $1,022.79 | 2022-2024 | Linq II, Cg Future, Mycarelink |
| Kestra Medical Technology Services, INC. | $1,021.06 | 2022-2025 | Assure Wcd |
| Amgen INC. | $991.45 | 2019-2025 | Repatha, Repatha |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $565.40 | 2019-2023 | Diamondback Peripheral |
| Pfizer INC. | $527.04 | 2020-2025 | |
| Exact Sciences Corporation | $475.49 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biotronik INC. | $473.41 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Passeo-18 |
| Merck Sharp & Dohme LLC | $384.32 | 2019-2025 | Verquvo, Steglatro |
| E.R. Squibb & Sons, L.L.C. | $357.09 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $301.86 | 2019-2022 | |
| Esperion Therapeutics, INC. | $258.17 | 2020-2024 | Nexletol |
| Alnylam Pharmaceuticals INC. | $252.63 | 2020-2025 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $241.94 | 2019-2022 | |
| Corcept Therapeutics | $202.86 | 2024-2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $183.44 | 2020-2025 | Xifaxan, Trulance |
| Recor Medical INC | $171.69 | 2025 | Paradise Ultrasound Renal Denervation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $168.39 | 2019-2025 | Lifevest |
| Stryker Corporation | $140.36 | 2025 | Limflow System |
| Lexicon Pharmaceuticals, INC. | $136.66 | 2023-2024 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $129.00 | 2023-2025 | Opsumit, Uptravi |
| Intra-Sana Laboratories | $127.01 | 2023-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Janssen Biotech, INC. | $113.65 | 2019 | |
| Amarin Pharma, INC. | $111.04 | 2021 | |
| Shockwave Medical, INC | $97.60 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Gilead Sciences, INC. | $94.77 | 2019-2021 | |
| Glaxosmithkline, LLC. | $85.28 | 2025 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $81.84 | 2021-2025 | |
| Heartflow, INC. | $79.79 | 2024-2025 | |
| Bridgebio Pharma, INC. | $72.54 | 2025 | Attruby |
| Preventice Services, LLC | $64.53 | 2020-2021 | |
| Agepha Pharma Fz LLC | $50.27 | 2024 | Lodoco |
| Dexcom, INC. | $38.63 | 2021-2024 | Dexcom G6 Transmitter |
| Smith+Nephew, INC. | $31.48 | 2019 | |
| Vifor Pharma, INC. | $30.73 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $28.36 | 2020 | |
| Medicomp INC | $27.70 | 2025 | Telepatch Cardiac Monitor |
| Philips North America LLC | $26.20 | 2025 | Holter |
| Vivaquant INC, Dba Rhythm Express | $22.07 | 2025 | Rhythm Express |
| Baxter Healthcare | $21.36 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Tactile Systems Technology INC | $20.90 | 2025 | Flexitouch Plus, Nimbl |
| Coala Life INC | $20.87 | 2021 | |
| Edwards Lifesciences Corporation | $19.08 | 2019 | |
| Terumo Medical Corporation | $18.89 | 2020 | |
| Althera Pharmaceuticals LLC | $17.90 | 2021 | |
| Glycomark, INC. | $17.24 | 2019 | |
| Cequr Corporation | $16.47 | 2022 | |
| Atricure, INC. | $16.40 | 2021 | |
| Lundbeck LLC | $14.01 | 2019 | |
| Mannkind Corporation | $13.57 | 2020 | |
| Astellas Pharma US INC | $13.39 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.